AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Hipgnosis Songs Fund Limited

Director's Dealing Nov 14, 2022

6274_dirs_2022-11-14_066c4603-3a41-4b5d-86a0-e54a11d25df9.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3502G

Hipgnosis Songs Fund Limited

14 November 2022

14 November 2022

Hipgnosis Songs Fund Limited

("Hipgnosis" or the "Company")

Notification of Transactions of Persons Discharging Managerial Responsibilities (PDMRs)

The Company announces that it has been advised that Andrew Sutch, a Director of the Company, has acquired 938 ordinary shares in the Company ("Ordinary Shares") following the automatic re-investment of dividend. Following this transaction, Mr. Sutch holds a total of 62,993 Ordinary Shares, which equates to 0.005% of the issued share capital.

Details of the transaction can be found in the Notification of Dealing Form below.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Andrew Sutch
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Hipgnosis Songs Fund Limited
b) LEI 213800XJIPNDVKXMOC11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
HIPGNOSIS SONGS FUND LIMITED, ORDINARY SHARES

GG00BFYT9H72
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s)

85.9 pence
Volume(s)

938
d) Aggregated information

- Aggregated volume

- Price

- Principal amount
938

85.9p

£806.10
e) Date of the transaction 11 November 2022
f) Place of the transaction London Stock Exchange, Main Market
For further information please contact:

Hipgnosis Song Management

Merck Mercuriadis

Chris Helm

Giles Croot (Media)

Rufina Pavry (Investors)
+44 (0)20 4542 1511

+44 (0)20 4542 1530
Singer Capital Markets - Joint Corporate Broker

James Moat / James Maxwell / Alex Emslie (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales)
+44 (0)20 7496 3000
J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

James Bouverat (Sales)
+44 (0)20 7742 4000
RBC Capital Markets - Joint Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

Lisa Tugwell / Anastasia Mikhailova (Sales)
+44 (0)20 7635 4000
Ocorian - Company Secretary & Administrator

Lorna Zimny
+44 (0) 28 9693 0222
The Outside Organisation

Alan Edwards / Nick Caley
+44 (0)7711 081 843
FTI Consulting

Neil Doyle / Paul Harris / Laura Ewart
+44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646
All US music publicity enquiries

Fran Defeo
+1 917 767 5255

Notes to Editors

About Hipgnosis Songs Fund

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of almost £1.3 billion (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019, July 2020, September 2020, February 2021 and July 2021. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market, and in March 2020 became a constituent of the FTSE 250 Index. Since April 2021, the Company has been resident in the UK for tax purposes and is recognised as an investment trust under applicable HMRC regulations.

About Hipgnosis Song Management Limited

The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBUBDBIDBDGDS

Talk to a Data Expert

Have a question? We'll get back to you promptly.